NewAmsterdam Pharma NAMS
NASDAQ NAMS
$21.49 -0.01 (-0.05%)
At close: Oct 21, 2026 · 4:00 PM EDT

NewAmsterdam Pharma (NAMS) Common Stock Issued (2023 - 2026)

Updated

Analysis

NewAmsterdam Pharma (NAMS) Common Stock Issued (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 359.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 43.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 6.00 Mn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 9.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 NewAmsterdam Pharma 2.66 Bn 49.48 Mn - 11.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.04 Mn
Mar 31, 2026 11.07 Mn
Dec 31, 2025 13.68 Mn
Sep 30, 2025 5.89 Mn
Jun 30, 2025 3.43 Mn
Mar 31, 2025 8.11 Mn
Dec 31, 2024 1.61 Mn
Sep 30, 2024 58,000.00
Jun 30, 2024 4.66 Mn
Mar 31, 2024 9.20 Mn
Sep 30, 2023 186,000.00
Jun 30, 2023 6.33 Mn
Mar 31, 2023 2.39 Mn
API Access

NewAmsterdam Pharma Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=NAMS&period=max&api_key=YOUR_API_KEY